• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

芳香化酶在女性癌症中的表达。

Aromatase expression in women's cancers.

作者信息

Bulun Serdar E, Simpson Evan R

机构信息

Department of Obstetric and Gynecology, Northwestern University, Chicago, IL 60611, USA.

出版信息

Adv Exp Med Biol. 2008;630:112-32. doi: 10.1007/978-0-387-78818-0_8.

DOI:10.1007/978-0-387-78818-0_8
PMID:18637488
Abstract

Estrogen has been positively linked to the pathogenesis and growth of three common women's cancers (breast, endometrium and ovary). A single gene encodes the key enzyme for estrogen biosynthesis named aromatase, inhibition of which effectively eliminates estrogen production in the entire body. Aromatase inhibitors successfully treat breast cancer, whereas their roles in endometrial and ovarian cancers are less dear. Ovary, testis, adipose tissue, skin, hypothalamus and placenta express aromatase normally, whereas breast, endometrial and ovarian cancers overexpress aromatase and produce local estrogen exerting paracrine and intracrine effects. Tissue specific promoters distributed over a 93 kilobase regulatory region upstream of a common coding region alternatively control aromatase expression. A distinct set of transcription factors regulates each promoter in a signaling pathway- and tissue-specific manner. In cancers ofbreast, endometrium and ovary, aromatase expression is primarly regulated by increased activity of the proximally located promoter 1.3/II region. Promoters I.3 and II lie 215 bp from each other and are coordinately stimulated by PGE2 via a cAMP-PKA-dependent pathway. In breast adipose fibroblasts exposed to PGE2 secreted by malignant epithelial cells, activation of PKC potentiates cAMP-PKA-dependent induction ofaromatase. Thus, inflammatory substances such as PGE2 may play important roles in inducing local production of estrogen that promotes tumor growth.

摘要

雌激素与三种常见的女性癌症(乳腺癌、子宫内膜癌和卵巢癌)的发病机制及生长呈正相关。一种单一基因编码雌激素生物合成的关键酶——芳香化酶,抑制该酶可有效消除全身的雌激素生成。芳香化酶抑制剂可成功治疗乳腺癌,但其在子宫内膜癌和卵巢癌中的作用尚不清楚。卵巢、睾丸、脂肪组织、皮肤、下丘脑和胎盘正常表达芳香化酶,而乳腺癌、子宫内膜癌和卵巢癌则过度表达芳香化酶并产生局部雌激素,发挥旁分泌和自分泌作用。分布在一个共同编码区上游93千碱基调控区域的组织特异性启动子交替控制芳香化酶的表达。一组独特的转录因子以信号通路和组织特异性的方式调节每个启动子。在乳腺癌、子宫内膜癌和卵巢癌中,芳香化酶的表达主要受近端启动子1.3/II区域活性增加的调控。启动子I.3和II彼此相距215 bp,并通过cAMP-PKA依赖途径受到前列腺素E2(PGE2)的协同刺激。在暴露于恶性上皮细胞分泌的PGE2的乳腺脂肪成纤维细胞中,蛋白激酶C(PKC)的激活增强了cAMP-PKA依赖的芳香化酶诱导作用。因此,诸如PGE2等炎症物质可能在诱导促进肿瘤生长的局部雌激素产生中发挥重要作用。

相似文献

1
Aromatase expression in women's cancers.芳香化酶在女性癌症中的表达。
Adv Exp Med Biol. 2008;630:112-32. doi: 10.1007/978-0-387-78818-0_8.
2
Aromatase excess in cancers of breast, endometrium and ovary.乳腺癌、子宫内膜癌和卵巢癌中的芳香化酶过量。
J Steroid Biochem Mol Biol. 2007 Aug-Sep;106(1-5):81-96. doi: 10.1016/j.jsbmb.2007.05.027. Epub 2007 May 24.
3
Regulation of aromatase expression in estrogen-responsive breast and uterine disease: from bench to treatment.雌激素反应性乳腺和子宫疾病中芳香化酶表达的调控:从实验台到治疗
Pharmacol Rev. 2005 Sep;57(3):359-83. doi: 10.1124/pr.57.3.6.
4
Estrogen production and action.雌激素的产生与作用。
J Am Acad Dermatol. 2001 Sep;45(3 Suppl):S116-24. doi: 10.1067/mjd.2001.117432.
5
A novel role of sodium butyrate in the regulation of cancer-associated aromatase promoters I.3 and II by disrupting a transcriptional complex in breast adipose fibroblasts.丁酸钠通过破坏乳腺脂肪成纤维细胞中的转录复合物在癌症相关芳香化酶启动子I.3和II调控中的新作用。
J Biol Chem. 2006 Feb 3;281(5):2585-97. doi: 10.1074/jbc.M508498200. Epub 2005 Nov 21.
6
The human CYP19 (aromatase P450) gene: update on physiologic roles and genomic organization of promoters.人类CYP19(芳香化酶P450)基因:启动子的生理作用和基因组组织的最新进展
J Steroid Biochem Mol Biol. 2003 Sep;86(3-5):219-24. doi: 10.1016/s0960-0760(03)00359-5.
7
Prostaglandin E(2) induces breast cancer related aromatase promoters via activation of p38 and c-Jun NH(2)-terminal kinase in adipose fibroblasts.前列腺素E(2)通过激活脂肪成纤维细胞中的p38和c-Jun氨基末端激酶诱导乳腺癌相关芳香化酶启动子。
Cancer Res. 2007 Sep 15;67(18):8914-22. doi: 10.1158/0008-5472.CAN-06-4751.
8
Aromatase in aging women.老年女性体内的芳香化酶
Semin Reprod Endocrinol. 1999;17(4):349-58. doi: 10.1055/s-2007-1016244.
9
Regulation of aromatase P450 expression in endometriotic and endometrial stromal cells by CCAAT/enhancer binding proteins (C/EBPs): decreased C/EBPbeta in endometriosis is associated with overexpression of aromatase.CCAAT/增强子结合蛋白(C/EBPs)对子宫内膜异位症和子宫内膜基质细胞中芳香化酶P450表达的调控:子宫内膜异位症中C/EBPβ的降低与芳香化酶的过表达相关。
J Clin Endocrinol Metab. 2002 May;87(5):2336-45. doi: 10.1210/jcem.87.5.8486.
10
Prostaglandin E2 stimulates aromatase expression in endometriosis-derived stromal cells.前列腺素E2刺激子宫内膜异位症来源的基质细胞中芳香化酶的表达。
J Clin Endocrinol Metab. 1997 Feb;82(2):600-6. doi: 10.1210/jcem.82.2.3783.

引用本文的文献

1
D-chiro-inositol effectively counteracts endometriosis in a mouse model.D-手性肌醇在小鼠模型中可有效对抗子宫内膜异位症。
Mol Med. 2025 Apr 11;31(1):134. doi: 10.1186/s10020-025-01178-6.
2
Effects of Overweight on Risk of Thyroid Nodules in Children and Adolescents: The Fukushima Health Management Survey.超重对儿童和青少年甲状腺结节风险的影响:福岛健康管理调查
J Clin Endocrinol Metab. 2025 Jan 21;110(2):e478-e486. doi: 10.1210/clinem/dgae161.
3
New insights for gynecological cancer therapies: from molecular mechanisms and clinical evidence to future directions.
妇科癌症治疗的新见解:从分子机制和临床证据到未来方向。
Cancer Metastasis Rev. 2023 Sep;42(3):891-925. doi: 10.1007/s10555-023-10113-2. Epub 2023 Jun 27.
4
Hormonal and Genetic Regulatory Events in Breast Cancer and Its Therapeutics: Importance of the Steroidogenic Acute Regulatory Protein.乳腺癌及其治疗中的激素和遗传调控事件:类固醇生成急性调节蛋白的重要性
Biomedicines. 2022 Jun 3;10(6):1313. doi: 10.3390/biomedicines10061313.
5
The estrogen receptor beta agonist liquiritigenin enhances the inhibitory effects of the cholesterol biosynthesis inhibitor RO 48-8071 on hormone-dependent breast-cancer growth.雌激素受体β激动剂甘草查尔酮增强胆固醇生物合成抑制剂 RO 48-8071 对激素依赖性乳腺癌生长的抑制作用。
Breast Cancer Res Treat. 2022 Feb;192(1):53-63. doi: 10.1007/s10549-021-06487-y. Epub 2022 Jan 17.
6
Estradiol Signaling at the Heart of Folliculogenesis: Its Potential Deregulation in Human Ovarian Pathologies.雌激素信号在卵泡发生中的核心作用:其在人类卵巢病变中的潜在失调。
Int J Mol Sci. 2022 Jan 3;23(1):512. doi: 10.3390/ijms23010512.
7
SARS-CoV-2 infection negatively affects ovarian function in ART patients.SARS-CoV-2 感染会对接受辅助生殖技术(ART)的患者的卵巢功能产生负面影响。
Biochim Biophys Acta Mol Basis Dis. 2022 Jan 1;1868(1):166295. doi: 10.1016/j.bbadis.2021.166295. Epub 2021 Oct 27.
8
Cigarette Smoking and Estrogen-Related Cancer.吸烟与雌激素相关癌症。
Cancer Epidemiol Biomarkers Prev. 2021 Aug;30(8):1462-1471. doi: 10.1158/1055-9965.EPI-20-1803. Epub 2021 May 14.
9
Estrogen disorders: Interpreting the abnormal regulation of aromatase in granulosa cells (Review).雌激素紊乱:解析颗粒细胞中芳香化酶的异常调节(综述)。
Int J Mol Med. 2021 May;47(5). doi: 10.3892/ijmm.2021.4906. Epub 2021 Mar 11.
10
A Role for Estrogen Receptor alpha36 in Cancer Progression.雌激素受体 α36 在癌症进展中的作用。
Front Endocrinol (Lausanne). 2020 Jul 31;11:506. doi: 10.3389/fendo.2020.00506. eCollection 2020.